FDA Adverse Event Death Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 1678638 · Received May 7, 2010

Report

Report Number
2953200-2010-00790
Event Type
Death
Date Received
May 7, 2010
Date of Event
June 9, 2010
Report Date
November 21, 2013
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

AN ENDEAVOR SPRINT RX DRUG-ELUTING STENT WAS IMPLANTED TO THE DISTAL LAD. AN ENDEAVOR SPRINT STENT WAS IMPLANTED TO THE PROXIMAL LAD. A SECOND ENDEAVOR SPRINT STENT WAS IMPLANTED OVERLAPPING THE FIRST STENT TO TREAT A DISSECTION IN THE PROXIMAL LAD. (MFR REPORT# 2953200-2010-00790, 2953200-2010-00791, 2953200-2010-00792). THE PATIENT WAS DISCHARGED THE FOLLOWING DAY. AT THE 30 DAY FOLLOW UP THE PATIENT HAD STABLE ANGINA. APPROXIMATELY 4 MONTHS POST INDEX PROCEDURE THE PATIENT HAD INSTENT RESTENOSIS AND SUSPECTED STENT THROMBOSIS. TVR WAS PERFORMED TO THE PROXIMAL LAD. THE INVESTIGATOR STATED THAT THERE WAS A DEFINITE RELATIONSHIP TO THE STUDY DEVICE AND NO RELATIONSHIP TO THE PROCEDURE. APPROXIMATELY 5 1/2 MONTHS POST INDEX PROCEDURE THE PATIENT WAS HOSPITALIZED DUE TO A GASTROINTESTINAL BLEED. THE PATIENT HAD 2 DAY RECTAL BLEEDING, MEDICATION WAS ADMINISTERED AND A COLONOSCOPY WAS PERFORMED. THE PATIENT RECOVERED WITH TREATMENT. THE INVESTIGATOR STATED THAT THERE WAS NO RELATIONSHIP OF THE GASTROINTESTINAL BLEED AND THE STUDY STENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC CARDIOVASCULAR GALWAY

Patients

Seq Age Sex Outcome Treatment
1 85 YR Female Required Intervention| D